Our CSR policy

Download our 2023 Sustainability report

 

Sustainability has been a long standing focus at LXO.  Following our acquisition by Stanley Capital, it has risen to the forefront as a central performance imperative.

To date, we have taken key steps that follow a long-lasting will : improve our sustainable responsibility and add those KPIs to our annual objectives.

  • 95% of production in Europe (including 52% in France)
  • Maintaining diversity and gender equality in a context of strong growth in the number of employees (+37%)
  • Integration of Noden Pharma, which we acquired in 2022, into our reporting parameters
  • Reduction of our CO2e/M€ emissions from 115 tons in 2022 to 96 Co2e/M€ in 2023

 

We are aware of our accountability to society for a multifaceted responsibility at the heart of today’s major issues.

By aligning our objectives and ambitions into the PACTES programme of the LEEM professional organisation (patients, supply, collective, transparency, environment, strategy), we are part of a plan for long-term societal commitment based on voluntary action by drug companies.

 

Raise awareness among the medical profession

In collaboration with the French Committee for the Fightagainst Hypertension (CFLHTA), we conducted a survey of 300+ general practitioners to assess the current state ofhypertension management.

 

Internship and work-study programs

100% of our work-study students who were available for permanent positions and were offered a role within the company, accepted the position.

 

A zero tolerance approach to corruption

Our employees adhere to a strict code od conduct and robust anto-corruption policies. We have also implemented a code of ethics for all our suppliers.

 

Digitalization and reduction of emissions

LXO is pursuing dematerialization both externally, with regulatory agencies, customers and partners, and internally, with our employees : digitalizing procedures, invoices, collaborative tools, pay slips, agreements and contracts.

We saved approximatively 2.569 kg of CO2, 26.897 L of water, 1.093 kg of wood, 177 kg of waste and 28.078 pages of paper.

 

Social impact throught charity

We continued our efforts to raise awareness by taking part in various initiatives : Pinkctober (breast cancer awareness) and Course des Héros, raising over €3.500 for charity.

 

Engagement with industry groups

LXO Group is a member and contributor of LEEM and AMLIS, and partake in a number of initiatives within the organizations each year.

We are particularly proud of the landmark agreement signed by the healthcare industry in July 2023, under the leadership of LEEM, aimed at promoting the climate transition which commits the pharmaceutical sector to a path of decarbonisation.

 

 

 

Know more about “the 17 Sustainable Development Goals” from UN website